IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma

NCT01333605 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
43
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fudan University